Updated Jul 16, 2026
LaPlume Joseph W has filed 2 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $4K. Lifetime open-market sales: $324K.

Joseph W. Laplume is the Executive Vice President of Corporate Strategy and Development at Charles River Laboratories International, Inc. He has been involved in multiple SEC filings related to his role in the company, indicating his active participation in corporate governance and strategy.
| Role | EVP, Corp Strategy & Develop |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 235 | $180.71 | $42K |
| 2026-06-02 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 744 | $180.71 | $134K |
| 2026-06-02 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | A — Grant or award | 5.3K | $180.71 | $950K |
| 2026-05-28 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 185 | $156.73 | $29K |
| 2026-05-28 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 243 | $160.30 | $39K |
| 2026-03-04 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | P — Open-market purchase | 25 | $174.54 | $4K |
| 2026-02-03 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 1.7K | $211.68 | $370K |
| 2026-02-03 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | A — Grant or award | 5.5K | $0.00 | |
| 2026-01-20 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | S — Open-market sale | 400 | $163.72 | $65K |
| 2025-08-18 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | S — Open-market sale | 800 | $157.60 | $126K |
| 2025-08-07 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | S — Open-market sale | 400 | $150.04 | $60K |
| 2025-06-05 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | G — Bona-fide gift | 385 | $0.00 | |
| 2025-05-30 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 155 | $135.63 | $21K |
| 2025-05-30 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | A — Grant or award | 6.7K | $135.63 | $910K |
| 2025-05-26 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 83 | $138.65 | $12K |
| 2025-05-26 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 122 | $136.73 | $17K |
| 2025-05-26 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | F — Tax withholding / forfeiture | 161 | $136.73 | $22K |
| 2025-05-13 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | S — Open-market sale | 500 | $145.41 | $73K |
Joseph W. Laplume is the Executive Vice President of Corporate Strategy and Development at Charles River Laboratories International, Inc. He has been involved in multiple SEC filings related to his role in the company, indicating his active participation in corporate governance and strategy.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($4K) and 4 open-market sales ($324K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LaPlume Joseph W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.